These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

184 related items for PubMed ID: 17077323

  • 1. Bone morphogenic protein antagonist Drm/gremlin is a novel proangiogenic factor.
    Stabile H, Mitola S, Moroni E, Belleri M, Nicoli S, Coltrini D, Peri F, Pessi A, Orsatti L, Talamo F, Castronovo V, Waltregny D, Cotelli F, Ribatti D, Presta M.
    Blood; 2007 Mar 01; 109(5):1834-40. PubMed ID: 17077323
    [Abstract] [Full Text] [Related]

  • 2. Angiopoietin-1 mediates the proangiogenic activity of the bone morphogenic protein antagonist Drm.
    Mitola S, Moroni E, Ravelli C, Andres G, Belleri M, Presta M.
    Blood; 2008 Aug 15; 112(4):1154-7. PubMed ID: 18505784
    [Abstract] [Full Text] [Related]

  • 3. Cyclic adenosine monophosphate-response element-binding protein mediates the proangiogenic or proinflammatory activity of gremlin.
    Corsini M, Moroni E, Ravelli C, Andrés G, Grillo E, Ali IH, Brazil DP, Presta M, Mitola S.
    Arterioscler Thromb Vasc Biol; 2014 Jan 15; 34(1):136-45. PubMed ID: 24233491
    [Abstract] [Full Text] [Related]

  • 4. Drm/Gremlin, a BMP antagonist, defines the interbud region during feather development.
    Bardot B, Lecoin L, Fliniaux I, Huillard E, Marx M, Viallet JP.
    Int J Dev Biol; 2004 Jan 15; 48(2-3):149-56. PubMed ID: 15272379
    [Abstract] [Full Text] [Related]

  • 5. Gremlin is a novel agonist of the major proangiogenic receptor VEGFR2.
    Mitola S, Ravelli C, Moroni E, Salvi V, Leali D, Ballmer-Hofer K, Zammataro L, Presta M.
    Blood; 2010 Nov 04; 116(18):3677-80. PubMed ID: 20660291
    [Abstract] [Full Text] [Related]

  • 6. Heparan sulfate proteoglycans mediate the angiogenic activity of the vascular endothelial growth factor receptor-2 agonist gremlin.
    Chiodelli P, Mitola S, Ravelli C, Oreste P, Rusnati M, Presta M.
    Arterioscler Thromb Vasc Biol; 2011 Dec 04; 31(12):e116-27. PubMed ID: 21921258
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Monomeric gremlin is a novel vascular endothelial growth factor receptor-2 antagonist.
    Grillo E, Ravelli C, Corsini M, Ballmer-Hofer K, Zammataro L, Oreste P, Zoppetti G, Tobia C, Ronca R, Presta M, Mitola S.
    Oncotarget; 2016 Jun 07; 7(23):35353-68. PubMed ID: 27174917
    [Abstract] [Full Text] [Related]

  • 10. BMP4 activation and secretion are negatively regulated by an intracellular gremlin-BMP4 interaction.
    Sun J, Zhuang FF, Mullersman JE, Chen H, Robertson EJ, Warburton D, Liu YH, Shi W.
    J Biol Chem; 2006 Sep 29; 281(39):29349-56. PubMed ID: 16880207
    [Abstract] [Full Text] [Related]

  • 11. The Xenopus dorsalizing factor Gremlin identifies a novel family of secreted proteins that antagonize BMP activities.
    Hsu DR, Economides AN, Wang X, Eimon PM, Harland RM.
    Mol Cell; 1998 Apr 29; 1(5):673-83. PubMed ID: 9660951
    [Abstract] [Full Text] [Related]

  • 12. The binding of the bone morphogenetic protein antagonist gremlin to kidney heparan sulfate: Such binding is not essential for BMP antagonism.
    Tatsinkam AJ, Rune N, Smith J, Norman JT, Mulloy B, Rider CC.
    Int J Biochem Cell Biol; 2017 Feb 29; 83():39-46. PubMed ID: 27979781
    [Abstract] [Full Text] [Related]

  • 13. Effects of TGF-beta2, BMP-4, and gremlin in the trabecular meshwork: implications for glaucoma.
    Wordinger RJ, Fleenor DL, Hellberg PE, Pang IH, Tovar TO, Zode GS, Fuller JA, Clark AF.
    Invest Ophthalmol Vis Sci; 2007 Mar 29; 48(3):1191-200. PubMed ID: 17325163
    [Abstract] [Full Text] [Related]

  • 14. Gremlin-1: An endogenous BMP antagonist induces epithelial-mesenchymal transition and interferes with redifferentiation in fetal RPE cells with repeated wounds.
    Li D, Yuan D, Shen H, Mao X, Yuan S, Liu Q.
    Mol Vis; 2019 Mar 29; 25():625-635. PubMed ID: 31700227
    [Abstract] [Full Text] [Related]

  • 15. Mapping the heparin-binding site of the BMP antagonist gremlin by site-directed mutagenesis based on predictive modelling.
    Tatsinkam AJ, Mulloy B, Rider CC.
    Biochem J; 2015 Aug 15; 470(1):53-64. PubMed ID: 26251446
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Bone morphogenetic protein antagonist gremlin 1 is widely expressed by cancer-associated stromal cells and can promote tumor cell proliferation.
    Sneddon JB, Zhen HH, Montgomery K, van de Rijn M, Tward AD, West R, Gladstone H, Chang HY, Morganroth GS, Oro AE, Brown PO.
    Proc Natl Acad Sci U S A; 2006 Oct 03; 103(40):14842-7. PubMed ID: 17003113
    [Abstract] [Full Text] [Related]

  • 18. Differential gene expression and regulation of the bone morphogenetic protein antagonists follistatin and gremlin in normal and osteoarthritic human chondrocytes and synovial fibroblasts.
    Tardif G, Hum D, Pelletier JP, Boileau C, Ranger P, Martel-Pelletier J.
    Arthritis Rheum; 2004 Aug 03; 50(8):2521-30. PubMed ID: 15334466
    [Abstract] [Full Text] [Related]

  • 19. DRM/GREMLIN (CKTSF1B1) maps to human chromosome 15 and is highly expressed in adult and fetal brain.
    Topol LZ, Modi WS, Koochekpour S, Blair DG.
    Cytogenet Cell Genet; 2000 Aug 03; 89(1-2):79-84. PubMed ID: 10894942
    [Abstract] [Full Text] [Related]

  • 20. Cancer-associated fibroblast-derived Gremlin 1 promotes breast cancer progression.
    Ren J, Smid M, Iaria J, Salvatori DCF, van Dam H, Zhu HJ, Martens JWM, Ten Dijke P.
    Breast Cancer Res; 2019 Sep 18; 21(1):109. PubMed ID: 31533776
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.